Study finds appointing former politicians and regulators to boards of directors or management teams influences corporate mergers and acquisitions and improves the financial performance of acquiring companies.
FAU has entered into a licensing agreement with Neuro Pharmalogics, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases.
FAU Harbor Branch study shows the relationship between changing sea ice and beluga whale migration and habitat patterns of several populations over two decades of dramatic sea ice changes in the Pacific Arctic.
FAU Harbor Branch scientists are researching ways to create a biosynthetic version of a compound found in a sea sponge that is very active against cancer cells.
FAU researchers and collaborators conducted a first-of-its-kind longitudinal study on twins to identify the degree to which siblings contribute to the increase in delinquent behavior and alcohol misuse.
This Hispanic Serving Institution project (Title III) will increase underrepresented Hispanics in computer-related careers, and facilitate successful post-degree employment or graduate school enrollment.
A study on a plaque identifying toothpaste has shown significant reductions in dental plaque and inflammation throughout the body. These findings support the premise of reductions in heart attacks and strokes.
A group of Florida Atlantic University graduate students have three minutes to explain their research to an audience with no background in their area of study.
Phillip Boiselle, M.D., a leader in thoracic imaging and innovation, will serve as dean of FAU's Charles E. Schmidt College of Medicine effective in January 2017. He comes to FAU from Harvard Medical School.
Two FAU Harbor Branch scientists, along with collaborators, are assessing the health and abundance of sharks and rays in the Indian River Lagoon.